sarepta building
Pharma

Sarepta CEO to retire, citing 'shocking and ironic twist of fate'

Ingram’s departure comes at a crossroads for Sarepta, as the unwavering conviction that defined his tenure faces major commercial uncertainty.
Angus Liu Feb 26, 2026 11:30am
Boehringer Ingelheim

Boehringer's Hernexeos earns FDA's 2nd national priority nod

Feb 26, 2026 3:22pm
Obesity Power Rankings Who will challenge Lilly and Novo

Obesity Power Rankings: Who will challenge Lilly and Novo?

Feb 23, 2026 8:00am
The exterior of the Centers for Disease Control and Prevention campus in Chamblee Georgia March 18 2025

CDC advisory panel sets new date for delayed vaccine meeting

Feb 26, 2026 2:28pm
Community oncologys expanding role as cancer care grows more complex

Community oncology’s expanding role as cancer care grows more complex

Feb 23, 2026 8:00am
Graphic image of a compass above an unfolded map Orange background color

Eisai’s Kompass points the way to kidney cancer support

Feb 26, 2026 11:45am
More News

Argenx's Vyvgart posts ph. 3 win in ocular myasthenia gravis

Feb 26, 2026 11:18am
Fierce Biotech

Building biopharma: Why diversity by itself isn’t enough

Feb 26, 2026 9:30am

Viatris to cut 10% of workforce in 3-year overhaul

Feb 26, 2026 9:25am

BridgeBio CEO shrugs off recent Attruby pricing pressure fears

Feb 25, 2026 2:30pm